PharmaBoardroom

Days to Grant Registration for Innovative Drugs in Mexico

The below chart shows the average number of days taken to grant registration for innovative drugs. The previous number of days for Mexico (360) has…

Mexican Pharmaceutical Factsheet

The chart below shows the main investors into pharmaceuticals in Mexico and the main export destinations for Mexican pharmaceutical products. It also…

Manufacturing Costs in the Mexican Pharmaceutical Industry

This chart shows the manufacturing costs in the Mexican pharmaceutical industry (compared to the US in 2013). For more data on the Mexican market,…

Interview: Hatem Safei – Managing Director, Bayer Egypt

Bayer broke into the top ten multinationals in Egypt this year, after achieving a remarkable 110 percent growth over the last two years. General…

Interview: Ronald Brus – CEO, myTomorrows, The…

Harnessing the power of big data and the Internet, myTomorrows is working to help patients in need to access treatments that would otherwise not be…

R&D in Thailand – A way out of the Middle-income Trap?

Through greater government support for R&D, tax breaks for both foreign investors and domestic researchers and the creation of knowledge clusters,…

Interview: Onno van de Stolpe – CEO, Galapagos, The…

After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies…

Interview: Leo Le Duc – Director, Amsterdam Science Park,…

Leo Le Duc, Director of Amsterdam Science Park, explains the potential of Amsterdam Science Park as a world-class eco-system for start-ups, mature…

Interview: Andrea van Elsas – CSO & Hans van Eenennaam…

The CSO and COO of BioNovion talk about the company's recent acquisition by US-based biotech Aduro. BioNovion is a Dutch biopharma specialized in…

Interview: Stefan Braam – CEO, Pluriomics, The Netherlands

Stem cell technology can play a key role in improving the drug discovery process. The CEO of Pluriomics, a biotech company focused on development of…

Interview: Patrick Bourdet – President and CEO, AREVA Med,…

The president and CEO of AREVA Med, the medical subsidiary of AREVA Group, the biggest nuclear company in the world, discusses the circumstances that…

Interview: Dominique Giorgi – President, CEPS (Comité…

The President of CEPS, the French pricing agency, reveals the issues around the launch of the hepatitis C drug Sovaldi in 2014 and of CEPS´ role…

Tagged with